Visiox Pharmaceuticals, Inc. (“Visiox” or the “Company”), a commercial-stage biopharmaceutical company, and PowerUp Acquisition Corp. (“PowerUp”) (Nasdaq: PWUP) announce the execution of a definitive agreement for a business combination (the “Transaction” or the “Business Combination”) that would result in Visiox becoming a publicly traded company on the Nasdaq Capital Market (“Nasdaq”). The business combination is expected to close in the first quarter of 2024, and upon closing the combined company will be named Visiox Holdings, Inc. with its common stock and warrants expected to be listed on Nasdaq under the ticker symbols VSXP and VSXPW, respectively.
Read the full article: Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to Be Listed on Nasdaq through a Business Combination with PowerUp Acquisition Corp. //
Source: https://www.globenewswire.com/news-release/2023/12/27/2801345/0/en/Visiox-Pharmaceuticals-Inc-a-Commercial-Stage-Biopharmaceutical-Company-to-be-Listed-on-Nasdaq-Through-a-Business-Combination-with-PowerUp-Acquisition-Corp.html